Insider Transactions in Q2 2025 at Allscripts Healthcare Solutions, Inc. (MDRX)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 02
2025
|
Lisa Hammond SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,140
+25.03%
|
$232,560
$4.3 P/Share
|
Jun 02
2025
|
Tejal Vakharia SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
69,768
+15.26%
|
$279,072
$4.3 P/Share
|
Jun 02
2025
|
Vinit K Asar |
BUY
Grant, award, or other acquisition
|
Direct |
46,512
+45.1%
|
$186,048
$4.3 P/Share
|
Jun 02
2025
|
Carol J Zierhoffer |
BUY
Grant, award, or other acquisition
|
Direct |
46,512
+26.22%
|
$186,048
$4.3 P/Share
|
Jun 02
2025
|
Lou Silverman |
BUY
Grant, award, or other acquisition
|
Direct |
46,512
+45.1%
|
$186,048
$4.3 P/Share
|
Jun 02
2025
|
David B Stevens |
BUY
Grant, award, or other acquisition
|
Direct |
46,512
+27.77%
|
$186,048
$4.3 P/Share
|
Jun 02
2025
|
Susan Rodriguez |
BUY
Grant, award, or other acquisition
|
Direct |
46,512
+34.42%
|
$186,048
$4.3 P/Share
|
Jun 02
2025
|
Bruce C. Felt Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
46,512
+45.73%
|
$186,048
$4.3 P/Share
|
Jun 01
2025
|
Stonehill Capital Management LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
46,512
+45.73%
|
-
|
Jun 01
2025
|
Jonathan S Sacks Director |
BUY
Grant, award, or other acquisition
|
Direct |
46,512
+45.73%
|
-
|
May 31
2025
|
Stonehill Capital Management LLC Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,696
+50.0%
|
-
|
May 31
2025
|
Jonathan S Sacks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,696
+50.0%
|
-
|
May 25
2025
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,526
-1.3%
|
$6,104
$4.4 P/Share
|
May 09
2025
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-0.99%
|
$12,676
$4.3 P/Share
|
May 09
2025
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,087
-1.74%
|
$8,348
$4.3 P/Share
|
May 02
2025
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,893
-0.57%
|
$7,572
$4.4 P/Share
|
Apr 01
2025
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,481
-0.75%
|
$9,924
$4.25 P/Share
|
Apr 01
2025
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
227
-0.19%
|
$908
$4.25 P/Share
|